Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma?

Authors :: Zhang, C.‐Y.
He, Z.‐H.
Ahir, B.‐K.
Luo, C.‐P.
Peng, N.‐F.
Li, L.‐Q.
Source :: Alimentary Pharmacology & Therapeutics; Jan2017, Vol. 45 Issue 1, p181-182, 11p
Publication Year :: 2017
Abstract: Linked Content This article is linked to Lin et al papers. To view these articles visit https://doi.org/10.1111/apt.13774 and https://doi.org/10.1111/apt.13849. [ABSTRACT FROM AUTHOR]

Subjects :: ANTIVIRAL agents
HEPATITIS B treatment
LIVER cancer
CANCER risk factors

Full Text Access

Tools